首页> 外文期刊>International journal of oncology >FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome
【24h】

FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome

机译:FKBP10 / FKBP65在高级卵巢浆液性癌中的表达及其与患者预后的关系

获取原文
           

摘要

The frequent loss of chromosome?17 in epithelial ovarian carcinomas (EOC), particularly high-grade serous carcinomas (HGSC), has been attributed to the disruption of TP53 (at 17p13.1) and other chromosome?17 genes suspected to play a role in tumour suppressor pathways. In a transcriptome analysis of HGSC, we showed underexpression of a number of chromosome?17 genes, which included FKBP10 (at?17q21.1) and collagen?I?α?1 (COL1A1; at 17q21.33). FKBP10 codes for the immunophilin FKBP65 and is suspected to act as a chaperone for COL1A1. We have investigated FKBP10 (gene) and FKBP65 (protein) expression in HGSC samples and EOC cell lines that differ in their tumourigenic potential. COL1A1 expression was also investigated given the purported function of FKBP65. RT-PCR analysis verified underexpression of FKBP10 and COL1A1 in HGSCs (n=14) and six tumourigenic EOC cell lines, relative to normal ovarian surface epithelial cells and a non?tumourigenic EOC cell line. Immunohistochemistry analyses of 196 HGSC samples using tissue microarrays revealed variable staining intensities in the epithelial tumour component where only 7.8% and 1.0% of samples stained intensely for FKBP65 and COL1A1, respectively. Variable staining intensities were also observed for the stromal component where 23.6% and 24.1% stained intensely for FKBP65 and COL1A1, respectively. There was no significant correlation of staining intensity of either protein with disease stage. Staining of FKBP65 was clearly visible in normal epithelial cells of the ovarian surface and fallopian tube. There was a significant correlation between absence of FKBP65 staining in the epithelial cell component of the tumour and prolonged overall survival (p<0.001). Our results suggest that underexpression of FKBP65 protein is characteristic of HGSCs and that this expression profile may be linked to molecular pathways associated with an unfavourable outcome in cancer patients.
机译:在上皮性卵巢癌(EOC)中,特别是在高度浆液性癌(HGSC)中,?17染色体的频繁丢失,归因于TP53的破坏(在17p13.1处)以及其他怀疑在其中起作用的染色体17在肿瘤抑制途径中。在HGSC的转录组分析中,我们显示了许多17号染色​​体基因的低表达,其中包括FKBP10(17q21.1)和胶原蛋白Iαα1(COL1A1; 17q21.33)。 FKBP10编码亲免蛋白FKBP65,并被怀疑充当COL1A1的分子伴侣。我们研究了HGSC样品和EOC细胞系中具有致瘤潜力的FKBP10(基因)和FKBP65(蛋白质)表达。鉴于FKBP65的功能,还研究了COL1A1的表达。相对于正常卵巢表面上皮细胞和非致瘤性EOC细胞,RT-PCR分析证实了HGSC(n = 14)和六种致瘤性EOC细胞系中FKBP10和COL1A1的低表达。使用组织微阵列对196个HGSC样品进行的免疫组织化学分析显示,上皮肿瘤成分的染色强度可变,其中分别只有7.8%和1.0%的样品对FKBP65和COL1A1进行了强烈染色。还观察到基质成分的染色强度可变,其中FKBP65和COL1A1分别被强烈染色的23.6%和24.1%。两种蛋白的染色强度与疾病阶段没有显着相关性。 FKBP65的染色在卵巢表面和输卵管的正常上皮细胞中清晰可见。在肿瘤的上皮细胞成分中不存在FKBP65染色与延长的总生存期之间存在显着相关性(p <0.001)。我们的结果表明,FKBP65蛋白的低表达是HGSC的特征,并且该表达谱可能与癌症患者不良预后相关的分子途径有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号